Notice Received Under Section 249D of the Corporations Act
Dec 01, 2017 10:00 am UTC| Business
MELBOURNE, Australia, Dec. 01, 2017 -- Genetic Technologies Limited (ASX:GTG) (NASDAQ:GENE) (“Company”), advises that on 29 November it received a notice under Section 249D of the Corporations Act 2001 (Section 249D...
Meridian Refines Framework, Features and Functionality, Enhancing Administrator and User Experience
Dec 01, 2017 10:00 am UTC| Business
RESTON, Va., Dec. 01, 2017 -- Meridian Knowledge Solutions, a leading cloud-based learning management system (LMS) provider, announced today the availability of Meridian LMS® version 17.3. In this release five key areas...
Employee elected board member change in Zealand Pharma
Dec 01, 2017 08:20 am UTC| Business
Company announcement - No. 54/2017 Employee elected board member change in Zealand Pharma Copenhagen, December 1, 2017 - Zealand Pharma A/S ("ZEAL") announces that Rasmus Just, Director of Business...
MGX Minerals Engages Senator Richard Polanco (Ret.) to Direct California Lithium Brine Strategy
Dec 01, 2017 08:05 am UTC| Business
VANCOUVER, British Columbia, Dec. 01, 2017 -- MGX Minerals Inc. (“MGX” or the “Company”) (CSE:XMG) (FKT:1MG) (OTCQB:MGXMF) is please to announce it has retained former California Senate Majority Leader Richard Polanco...
Shire Appoints Andreas Busch, Ph D as Head of Research and Development and Chief Scientific Officer
Dec 01, 2017 08:01 am UTC| Business
Shire Appoints Andreas Busch, Ph D as Head of Research and Development and Chief Scientific Officer Howard Mayer, MD to become Chief Medical Officer Cambridge, MA - December 1, 2017 - Shire plc (LSE: SHP,...
CCEI Offers No-Cost Online Course Examining Inclusion and Children with Special Needs
Dec 01, 2017 08:00 am UTC| Business
Duluth, GA, Dec. 01, 2017 -- ChildCare Education Institute® (CCEI), an online child care training provider dedicated exclusively to the early care and education workforce, offers CCEI968: Inclusion and Children with...
Dec 01, 2017 07:30 am UTC| Business
NEW YORK, Dec. 01, 2017 -- The following statement is being issued by Levi Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired shares of Meridian Bioscience, Inc. (NASDAQ:VIVO) between...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update